The state-of-the-art combination of two single-cell RNA sequencing technologies has recently allowed the analysis of all CD45+ immune cells in HCC patients from different hepatic zones (tumor, adjacent liver, hepatic lymph node, blood, and tumor ascites) (238). The gene discussed is PTPRC; the disease is neoplasm.